Richard obtained a degree in Natural Sciences and a PhD in Organic Chemistry from the University of Cambridge. He then carried out a postdoc at Imperial College, London, ultimately leading the TeknoMed industrial collaboration. After a brief spell as an agrochemical Team Leader at Syngenta, UK, he moved to Almirall in Barcelona in 2002. Since 2008 he has been a program leader in Drug Discovery, supervising medicinal chemistry projects related to asthma, cough and pruritus. In 2015 he joined Minoryx Therapeutics as Director of Drug Discovery, up to the successful spin-out of the discovery platform as Gain Therapeutics. He is author of nearly 40 articles and patents.
This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.